Bigoni, Alessandro
Fahham, Lucas
Padula Ribeiro Pereira, Ana Carolina
de Oliveira, Ione Ayala Gualandi
Funding for this research was provided by:
Novartis Brazil
Article History
Received: 25 March 2025
Accepted: 3 March 2026
First Online: 2 April 2026
Declarations
:
: This study is based on anonymized, publicly available secondary datasets. Therefore, submission to the Ethics Committee was not required, as this complied with local laws and regulations.
: All authors consent to publication.
: Alessandro Bigoni, and Ione Ayala Gualandi de Oliveira are Novartis’ employees. Alessandro Bigoni holds a position as research scholar at the Harvard Healthcare System Innovation Lab (HSIL). Neither Harvard nor the HSIL were involved in this manuscript.